Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.07.495215Source: DataRank Database

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (21)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Li Zhuo ORCID,Kelsey Briggs ORCID,María Cristina Huertas-Díaz,Elizabeth R. Wrobel,Maria Najera

Live enrichment

PubMed:35702147 OpenAlex:https://openalex.org/W4281613711

National Institutes of Health

Grant: 3U01AI151698-03S2

University of Washington Arboviral Research Network (UWARN)

NIAID NIH HHS

Grant: U01 AI151698

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/06/08/2022.06.07.495215.full.pdf

repositoryhttps://doi.org/10.1101/2022.06.07.495215

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35702147

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9196109

Fields of Study

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 epidemiological studies0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Booster (rocketry)VirologyNasal administrationBooster doseCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVirusAerospace engineeringInfectious disease (medical specialty)EngineeringInternal medicineTiterArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants

FAIR Checklist

Authors (21)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)